Cargando…

Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns

STUDY DESIGN: Retrospective study. PURPOSE: To highlight risk factors, recurrence patterns and multimodal treatment in management of recurrent giant cell tumors (GCTs). OVERVIEW OF LITERATURE: GCTs of the spine are rare and challenging entities. Recurrences are very common and warrant complex manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Patil, Sanganagouda, Shah, Kunal Chandrakant, Bhojraj, Shekhar Yeshwant, Nene, Abhay Madhusudhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Spine Surgery 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764524/
https://www.ncbi.nlm.nih.gov/pubmed/26949468
http://dx.doi.org/10.4184/asj.2016.10.1.129
_version_ 1782417383310229504
author Patil, Sanganagouda
Shah, Kunal Chandrakant
Bhojraj, Shekhar Yeshwant
Nene, Abhay Madhusudhan
author_facet Patil, Sanganagouda
Shah, Kunal Chandrakant
Bhojraj, Shekhar Yeshwant
Nene, Abhay Madhusudhan
author_sort Patil, Sanganagouda
collection PubMed
description STUDY DESIGN: Retrospective study. PURPOSE: To highlight risk factors, recurrence patterns and multimodal treatment in management of recurrent giant cell tumors (GCTs). OVERVIEW OF LITERATURE: GCTs of the spine are rare and challenging entities. Recurrences are very common and warrant complex management to prevent multiple recurrences. Gross total resection is preferred over subtotal procedures to prevent recurrences. However, resection is associated with morbidity and mortality. Proper understanding of risk factors and a high index of suspicion helps to spot recurrences early and aids in subsequent management. METHODS: Ten patients (six females, four males) with recurrent GCTs underwent 17 interventions. There were six lesions in the thoracic spine, two in the cervical spine and two in the lumbar spine. Recurrences were managed with preoperative digital subtraction embolization, intralesional curettage and postoperative radiotherapy. RESULTS: The average age at intervention was 31.3 years. The average duration of recurrence in patients following index surgery in a tertiary care hospital and surgery elsewhere was 7.3 years and was 40 months, respectively. The minimum recurrence-free interval after the last recurrent surgery was 10 years. CONCLUSIONS: Our study reports the largest recurrence-free interval for GCTs. Recurrent GCTs are challenging entities. Understanding of risk factors and meticulous planning is required to prevent recurrences. Intralesional surgery could be a safer and effective modality in managing recurrences.
format Online
Article
Text
id pubmed-4764524
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Society of Spine Surgery
record_format MEDLINE/PubMed
spelling pubmed-47645242016-03-06 Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns Patil, Sanganagouda Shah, Kunal Chandrakant Bhojraj, Shekhar Yeshwant Nene, Abhay Madhusudhan Asian Spine J Clinical Study STUDY DESIGN: Retrospective study. PURPOSE: To highlight risk factors, recurrence patterns and multimodal treatment in management of recurrent giant cell tumors (GCTs). OVERVIEW OF LITERATURE: GCTs of the spine are rare and challenging entities. Recurrences are very common and warrant complex management to prevent multiple recurrences. Gross total resection is preferred over subtotal procedures to prevent recurrences. However, resection is associated with morbidity and mortality. Proper understanding of risk factors and a high index of suspicion helps to spot recurrences early and aids in subsequent management. METHODS: Ten patients (six females, four males) with recurrent GCTs underwent 17 interventions. There were six lesions in the thoracic spine, two in the cervical spine and two in the lumbar spine. Recurrences were managed with preoperative digital subtraction embolization, intralesional curettage and postoperative radiotherapy. RESULTS: The average age at intervention was 31.3 years. The average duration of recurrence in patients following index surgery in a tertiary care hospital and surgery elsewhere was 7.3 years and was 40 months, respectively. The minimum recurrence-free interval after the last recurrent surgery was 10 years. CONCLUSIONS: Our study reports the largest recurrence-free interval for GCTs. Recurrent GCTs are challenging entities. Understanding of risk factors and meticulous planning is required to prevent recurrences. Intralesional surgery could be a safer and effective modality in managing recurrences. Korean Society of Spine Surgery 2016-02 2016-02-16 /pmc/articles/PMC4764524/ /pubmed/26949468 http://dx.doi.org/10.4184/asj.2016.10.1.129 Text en Copyright © 2016 by Korean Society of Spine Surgery http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Patil, Sanganagouda
Shah, Kunal Chandrakant
Bhojraj, Shekhar Yeshwant
Nene, Abhay Madhusudhan
Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title_full Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title_fullStr Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title_full_unstemmed Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title_short Recurrent Spinal Giant Cell Tumors: A Study of Risk Factors and Recurrence Patterns
title_sort recurrent spinal giant cell tumors: a study of risk factors and recurrence patterns
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4764524/
https://www.ncbi.nlm.nih.gov/pubmed/26949468
http://dx.doi.org/10.4184/asj.2016.10.1.129
work_keys_str_mv AT patilsanganagouda recurrentspinalgiantcelltumorsastudyofriskfactorsandrecurrencepatterns
AT shahkunalchandrakant recurrentspinalgiantcelltumorsastudyofriskfactorsandrecurrencepatterns
AT bhojrajshekharyeshwant recurrentspinalgiantcelltumorsastudyofriskfactorsandrecurrencepatterns
AT neneabhaymadhusudhan recurrentspinalgiantcelltumorsastudyofriskfactorsandrecurrencepatterns